CONSTITUENT REPORT
Sabinene
Sabinene is a bicyclic monoterpene that appears across many spice, wood, citrus, and conifer oils in the AromaForge archive, often as part of the sharp peppery-pine lift in the top note. The accessible evidence base is strongest for chemical identity, wide natural occurrence, and a modest preclinical literature rather than for human clinical use. Archive-safe positioning is that sabinene is an analytically important aroma hydrocarbon with some experimental anti-inflammatory and anti-atrophy signals, but those findings remain preclinical and should not be presented as medical outcomes.
Chemical identity and composition
PubChem identifies sabinene as C10H16 with the IUPAC name 4-methylidene-1-propan-2-ylbicyclo[3.1.0]hexane, and NIST lists CAS 3387-41-5. In the archive it spans both trace and dominant roles, from 0.25% in Orange Sweet FCC Brazil to 38.52% in the general Plai record and 26.82% in Nutmeg.
Aroma and practical use
- Use the recorded woody, terpenic, citrus, pine, spicy, piney descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Review the flagged use concerns across every contributing oil and the selected dilution.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
cell based anti inflammatory activity
A PubMed-indexed abstract reported that sabinene significantly reduced NF-kB expression by 47 +/- 5% and lowered IL-6 secretion to 64 +/- 4% in the tested anti-inflammatory assay system, indicating direct preclinical anti-inflammatory activity under laboratory conditions.
Measured: NF-kB expression and IL-6 secretion
This experimental finding does not establish benefit, dose or safety in people using this blend.
fasting induced muscle atrophy model
A full-text rat study reported that sabinene reduced fasting-associated gastrocnemius muscle fiber atrophy and MuRF-1 expression, with the authors attributing the effect to suppression of ROS-mediated MAPK/MuRF-1 signaling in the experimental model.
Measured: muscle fiber area, muscle weight, MAPK phosphorylation, and MuRF-1 expression
This experimental finding does not establish benefit, dose or safety in people using this blend.
enzyme level biosynthesis
A 2024 structure-function study found that sabinene synthase generated product arrays composed of nearly 90% sabinene and showed strongest measured catalytic activity with Mn2+ or Co2+.
Measured: product profile and catalytic metal preference
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
Use concerns and concentration limits
Sensitization concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
No numeric constituent-specific use limit is available here. Missing is not an unrestricted-use clearance.
No constituent-specific IFRA dermal limit, phototoxicity warning, or human clinical safety study was verified in the reviewed public sources for isolated sabinene.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Because sabinene is usually encountered as part of monoterpene-rich oils rather than as a standalone consumer ingredient, archive copy should avoid implying isolated-compound tolerability beyond the available evidence.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
These are research candidates recorded in the interaction matrix. They do not add a proven-amplification bonus to the score.
LimoneneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Limonene report →How the effects were investigated
metal dependent sabinene synthase cyclization
A 2024 sabinene synthase study characterized a class I monoterpene cyclase that converts geranyl diphosphate into a product array dominated by sabinene, with optimal activity reported using Mn2+ or Co2+ and lower activity with Mg2+ or Ni2+.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (6)
- No human clinical literature specific to isolated sabinene was verified in this pass.
- Constituent-specific dermal sensitization and repeated-dose safety data were not located in the reviewed public sources.
- Most accessible bioactivity data come from preclinical models, so consumer-facing copy should keep benefit language conservative and non-medical.
- No constituent-specific numeric dermal reference is available here.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.
- Interaction candidates lack an attached source citation and remain unqualified.